HARBINGER ONCOLOGY Trademark

Trademark Overview

On Thursday, August 6, 2020, a trademark application was filed for HARBINGER ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the HARBINGER ONCOLOGY trademark a serial number of 90097064. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 22, 2024. This trademark is owned by Flagship Labs 66, Inc.. The HARBINGER ONCOLOGY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and preparations for use in the treatment and diagnosis of cancer

Diagnostic services for use in the treatment and diagnosis of cancer

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
harbinger oncology

General Information

Serial Number90097064
Word MarkHARBINGER ONCOLOGY
Filing DateThursday, August 6, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and preparations for use in the treatment and diagnosis of cancer
Goods and ServicesDiagnostic services for use in the treatment and diagnosis of cancer
NOT AVAILABLE"ONCOLOGY"
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 22, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHARBINGER HEALTH, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
Party NameFlagship Labs 66, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameFlagship Labs 66, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 1, 2020ASSIGNED TO EXAMINER
Tuesday, December 1, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 1, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 25, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 25, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, May 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 25, 2021ASSIGNED TO LIE
Tuesday, May 25, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, May 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 8, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, July 12, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, July 14, 2021NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 14, 2021EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 14, 2021EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, July 14, 2021COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, December 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 21, 2022SOU EXTENSION 1 FILED
Wednesday, September 21, 2022SOU EXTENSION 1 GRANTED
Wednesday, March 22, 2023SOU EXTENSION 2 GRANTED
Friday, September 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023SOU EXTENSION 2 FILED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 3 FILED
Wednesday, September 13, 2023SOU EXTENSION 3 GRANTED
Thursday, February 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2024ASSIGNED TO EXAMINER
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

oncology harbinger cancer diagnosis treatment pharmaceuticals research development scientific diagnostic therapeutic product